Drugs / Chuanzhi Tongluo Capsules
Chuanzhi Tongluo Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07121088 | Aug 2025 → Dec 2026 expected | cerebral infarction, diabetes mellitus | Guangzhou University of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chuanzhi Tongluo Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07121088 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “On the basis of standard treatment, a combined treatment plan of TCM universal treatment and syndrome-specific treatment was given.” NCT07121088 ↗ |
| Route | Oral | “4 capsules each time, orally, 3 times a day; administration from day 1 to day 14 of the disease.” NCT07121088 ↗ |